These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 15613622

  • 1. Inhibition of cGMP-specific phosphodiesterase type 5 reduces sodium excretion and arterial blood pressure in patients with NaCl retention and ascites.
    Thiesson HC, Jensen BL, Jespersen B, Schaffalitzky de Muckadell OB, Bistrup C, Walter S, Ottosen PD, Veje A, Skøtt O.
    Am J Physiol Renal Physiol; 2005 May; 288(5):F1044-52. PubMed ID: 15613622
    [Abstract] [Full Text] [Related]

  • 2. Increased activity of guanosine 3'-5'-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites.
    Angeli P, Jiménez W, Veggian R, Fasolato S, Volpin R, MacHenzie HS, Craighero R, Libera VD, Sticca A, Arroyo V, Gatta A.
    Hepatology; 2000 Feb; 31(2):304-10. PubMed ID: 10655250
    [Abstract] [Full Text] [Related]

  • 3. Effect of chronic administration of sildenafil on sodium retention and on the hemodynamic complications associated with liver cirrhosis in the rat.
    Ghali-Ghoul R, Tahseldar-Roumieh R, Sabra R.
    Eur J Pharmacol; 2007 Oct 15; 572(1):49-56. PubMed ID: 17610866
    [Abstract] [Full Text] [Related]

  • 4. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats.
    Ferreira-Melo SE, Yugar-Toledo JC, Coelho OR, De Luca IM, Tanus-Santos JE, Hyslop S, Irigoyen MC, Moreno H.
    Eur J Pharmacol; 2006 Aug 07; 542(1-3):141-7. PubMed ID: 16806160
    [Abstract] [Full Text] [Related]

  • 5. Effect of PDE5 inhibition combined with free oxygen radical scavenger therapy on erectile function in a diabetic animal model.
    De Young L, Yu D, Freeman D, Brock GB.
    Int J Impot Res; 2003 Oct 07; 15(5):347-54. PubMed ID: 14562136
    [Abstract] [Full Text] [Related]

  • 6. The cGMP-binding, cGMP-specific phosphodiesterase (PDE5): intestinal cell expression, regulation and role in fluid secretion.
    Sopory S, Kaur T, Visweswariah SS.
    Cell Signal; 2004 Jun 07; 16(6):681-92. PubMed ID: 15093609
    [Abstract] [Full Text] [Related]

  • 7. Stimulation of AQP2 membrane insertion in renal epithelial cells in vitro and in vivo by the cGMP phosphodiesterase inhibitor sildenafil citrate (Viagra).
    Bouley R, Pastor-Soler N, Cohen O, McLaughlin M, Breton S, Brown D.
    Am J Physiol Renal Physiol; 2005 Jun 07; 288(6):F1103-12. PubMed ID: 15644488
    [Abstract] [Full Text] [Related]

  • 8. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart.
    Forfia PR, Lee M, Tunin RS, Mahmud M, Champion HC, Kass DA.
    J Am Coll Cardiol; 2007 Mar 13; 49(10):1079-88. PubMed ID: 17349888
    [Abstract] [Full Text] [Related]

  • 9. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F, Tobe S, Legault L, Logan AG, Skorecki K, Blendis LM.
    Hepatology; 1993 Sep 13; 18(3):519-28. PubMed ID: 8395457
    [Abstract] [Full Text] [Related]

  • 10. Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation.
    Ni XP, Safai M, Gardner DG, Humphreys MH.
    Kidney Int; 2001 Apr 13; 59(4):1264-73. PubMed ID: 11260387
    [Abstract] [Full Text] [Related]

  • 11. Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility.
    Nagendran J, Archer SL, Soliman D, Gurtu V, Moudgil R, Haromy A, St Aubin C, Webster L, Rebeyka IM, Ross DB, Light PE, Dyck JR, Michelakis ED.
    Circulation; 2007 Jul 17; 116(3):238-48. PubMed ID: 17606845
    [Abstract] [Full Text] [Related]

  • 12. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B.
    Dan Med Bull; 1997 Apr 17; 44(2):191-207. PubMed ID: 9151012
    [Abstract] [Full Text] [Related]

  • 13. Postnatal maturation of phosphodiesterase 5 (PDE5) in piglet pulmonary arteries: activity, expression, effects of PDE5 inhibitors, and role of the nitric oxide/cyclic GMP pathway.
    Moreno L, Losada B, Cogolludo Al, Lodi F, Lugnier C, Villamor E, Moro M, Tamargo J, Pérez-Vizcaíno F.
    Pediatr Res; 2004 Oct 17; 56(4):563-70. PubMed ID: 15295092
    [Abstract] [Full Text] [Related]

  • 14. Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites.
    Thiesson HC, Skøtt O, Jespersen B, Schaffalitzky de Muckadell OB.
    Am J Gastroenterol; 2003 Jan 17; 98(1):180-6. PubMed ID: 12526955
    [Abstract] [Full Text] [Related]

  • 15. The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension.
    Bharani A, Mathew V, Sahu A, Lunia B.
    Indian Heart J; 2003 Jan 17; 55(1):55-9. PubMed ID: 12760589
    [Abstract] [Full Text] [Related]

  • 16. The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP levels in hippocampal slices.
    Rutten K, Vente JD, Sik A, Ittersum MM, Prickaerts J, Blokland A.
    Behav Brain Res; 2005 Oct 14; 164(1):11-6. PubMed ID: 16076505
    [Abstract] [Full Text] [Related]

  • 17. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.
    Schulze-Neick I, Hartenstein P, Li J, Stiller B, Nagdyman N, Hübler M, Butrous G, Petros A, Lange P, Redington AN.
    Circulation; 2003 Sep 09; 108 Suppl 1():II167-73. PubMed ID: 12970227
    [Abstract] [Full Text] [Related]

  • 18. Effects of phosphodiesterase inhibition on cortical spreading depression and associated changes in extracellular cyclic GMP.
    Wang M, Urenjak J, Fedele E, Obrenovitch TP.
    Biochem Pharmacol; 2004 Apr 15; 67(8):1619-27. PubMed ID: 15041479
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G, Lazzeri C, Pascale A, Sestini S, Bisi G, Sciagrà R, Vecchiarino S, Raggi VC, Barletta G, Laffi G, Gentilini P.
    Am J Gastroenterol; 1997 May 15; 92(5):852-7. PubMed ID: 9149200
    [Abstract] [Full Text] [Related]

  • 20. Sildenafil citrate therapy for pulmonary arterial hypertension.
    Galiè N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G, Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group.
    N Engl J Med; 2005 Nov 17; 353(20):2148-57. PubMed ID: 16291984
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.